approved EB-2 (NIW)

Ph.D. Student

Molecular Biology · Iran · 2025-09-03

Processing Time
180 days
Decision Date
2025-09-03
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cancer, a leading cause of death in the U.S., and aligns with the Cancer Moonshot initiative.

2 Well Positioned to Advance the Endeavor Met

The petitioner has authored 4 peer-reviewed articles with 36 citations and holds an advanced degree in medical immunology.

3 Balance of Interests Met

USCIS determined that the petitioner’s record of accomplishment and the urgency of national health priorities made a waiver of the job offer requirement beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's 4 peer-reviewed journal articles and 36 citations from independent researchers. Evidence showed one of her papers ranked in the top 20 percent of most cited works in immunology for its year, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.

Postdoctoral Researcher

Biotechnology · Mexico

WeGreened EB-2 (NIW) approved
Maryland 489 days 2022-08-22
The petitioner proposes to develop a highly quantitative understanding of the interactions between cancer cells and the immune system. He utilizes high-resolution microscopy, high-throughput flow cytometry, and mathematical modeling to design personalized cancer immunotherapies that are more effective than current treatments.

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 354 days 2025-04-03
The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.

Research Fellow

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 3 days 2023-10-19
The petitioner proposes to develop a multi-disciplinary screening platform to characterize drugs and biological molecules for immune system interventions. This work aims to reprogram the tumor microenvironment and enhance the efficacy of cancer immunotherapy treatments.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-03.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 180 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist